Rockwell Medical (RMTI) Projected to Post Quarterly Earnings on Thursday

Rockwell Medical (NASDAQ:RMTI) is expected to announce its earnings results before the market opens on Thursday, March 20th. Analysts expect the company to announce earnings of $0.02 per share and revenue of $23.65 million for the quarter. Investors that are interested in registering for the company’s conference call can do so using this link.

Rockwell Medical Price Performance

RMTI opened at $1.73 on Wednesday. The stock has a market cap of $55.91 million, a price-to-earnings ratio of -34.60 and a beta of 1.55. Rockwell Medical has a 1 year low of $1.38 and a 1 year high of $5.15. The company has a current ratio of 2.41, a quick ratio of 2.00 and a debt-to-equity ratio of 0.33. The stock has a fifty day moving average price of $1.89 and a 200 day moving average price of $2.64.

Analyst Upgrades and Downgrades

A number of analysts recently issued reports on RMTI shares. HC Wainwright reissued a “buy” rating and set a $7.00 price objective on shares of Rockwell Medical in a research report on Monday, December 23rd. StockNews.com cut Rockwell Medical from a “buy” rating to a “hold” rating in a research report on Friday, December 20th.

About Rockwell Medical

Rockwell Medical, Inc, together with its subsidiaries, operates as a healthcare company that engages in the development, manufacture, commercialization, and distribution of various hemodialysis products for dialysis providers worldwide. The company offers Triferic Dialysate and Triferic AVNU which are indicated to maintain hemoglobin in adult undergoing hemodialysis.